|
1） |
Hara M, Abe T, Sugawara S, Mizushima Y, Hoshi K, Irimajiri S, Hashimoto H, Yoshino S, Matsui N, Nobunaga M, Nakano S. Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis；A controlled, multicenter, double-blind, parallel-group study. Mod Rheumatol. 2007；17 (1)：1-9. |
|
2） |
Hara M, Abe T, Sugawara S, Mizushima Y, Hoshi K, Irimajiri S, Hashimoto H, Yoshino S, Matsui N, Nobunaga M. Long-term safety study of iguratimod in patients with rheumatoid arthritis. Mod Rheumatol. 2007；17 (1)：10-16. |
|
3） |
Ishiguro N, Yamamoto K, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Hara M. Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate；A randomized, double-blind, placebo-controlled trial. Mod Rheumatol. 2013 May；23 (3)：430-439. |
|
4） |
Lu LJ, Bao CD, Dai M, Teng JL, Fan W, Du F, Yang NP, Zhao YH, Chen ZW, Xu JH, He PG, Wu HX, Tao Y, Zhang MJ, Han XH, Li XF, Gu JR, Li JH, Yu H. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate. Arthritis Rheum. 2009 Jul 15；61 (7)：979-987. |
ログイン
お問い合わせ
書誌情報
